FDA Investigator: Camerson E. Moore

- Camerson E. Moore first started conducting FDA inspections in 2010, with the last inspection in 2024. Over that time, Camerson E. Moore has conducted 163 inspections at 152 companies across 154 sites.

Get Camerson Moore's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 First Time US Pharmaceuticals (India) Pvt Ltd., Navi Mumbai | 2024

Out-of-stock
Camerson E. Moore
Human Drugs Form 483

FDA 483 Rubicon Research Private Limited, Ambarnath | 2024

Out-of-stock
Camerson E. Moore
Human Drugs Form 483

FDA 483 RioCare India Pvt Ltd, Navi Mumbai | 2024

Out-of-stock
Camerson E. Moore
Human Drugs Form 483

FDA 483 Celgene International Sarl, Boudry | 2023

Out-of-stock
Camerson E. Moore
Human Drugs Form 483

FDA 483 Apotex Inc., Richmond Hill | 2022

Out-of-stock
Camerson E. Moore
Human Drug Form 483

FDA 483 LEC Custom Products, Inc., Mississauga | 2022

Out-of-stock
Camerson E. Moore
Human Drug Form 483